Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

被引:566
作者
Lobov, IB
Brooks, PC
Lang, RA [1 ]
机构
[1] Childrens Hosp Res Fdn, Dept Ophthalmol, Div Dev Biol, Cincinnati, OH 45229 USA
[2] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
关键词
angiogenesis; pupillary membrane;
D O I
10.1073/pnas.172161899
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Modulation of Tie2 receptor activity by its angiopoietin ligands is crucial for angiogenesis, blood vessel maturation, and vascular endothelium integrity. It has been proposed that angiopoietins 1 (Ang1) and 2 (Ang2) are pro- and anti-angiogenic owing to their respective agonist and antagonist signaling action through the Tie2 receptor. The function of Ang2 has remained controversial, however, with recent reports suggesting that in some circumstances, it may be pro-angiogenic. We have examined this issue using the transient ocular microvessel network called the pupillary membrane as a unique in vivo model for studying the effects of vascular regulators. We show that in vivo, in the presence of endogenous vascular endothelial growth factor (VEGF)-A, Ang2 promotes a rapid increase in capillary diameter, remodeling of the basal lamina, proliferation and migration of endothelial cells, and stimulates sprouting of new blood vessels. By contrast, Ang2 promotes endothelial cell death and vessel regression if the activity of endogenous VEGF is inhibited. These observations support a model for regulation of vascularity where VEGF can convert the consequence of Ang2 stimulation from anti-to pro-angiogenic.
引用
收藏
页码:11205 / 11210
页数:6
相关论文
共 29 条
[1]   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [J].
Asahara, T ;
Chen, DH ;
Takahashi, T ;
Fujikawa, K ;
Kearney, M ;
Magner, M ;
Yancopoulos, GD ;
Isner, JM .
CIRCULATION RESEARCH, 1998, 83 (03) :233-240
[2]   Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis [J].
Carmeliet, P ;
Lampugnani, MG ;
Moons, L ;
Breviario, F ;
Compernolle, V ;
Bono, F ;
Balconi, G ;
Spagnuolo, R ;
Oosthuyse, B ;
Dewerchin, M ;
Zanetti, A ;
Angellilo, A ;
Mattot, V ;
Nuyens, D ;
Lutgens, E ;
Clotman, F ;
de Ruiter, MC ;
Gittenberger-de Groot, A ;
Poelmann, R ;
Lupu, F ;
Herbert, JM ;
Collen, D ;
Dejana, E .
CELL, 1999, 98 (02) :147-157
[3]  
Diez-Roux G, 1999, DEVELOPMENT, V126, P2141
[4]  
DiezRoux G, 1997, DEVELOPMENT, V124, P3633
[5]  
Eggert A, 2000, CLIN CANCER RES, V6, P1900
[6]  
Etoh T, 2001, CANCER RES, V61, P2145
[7]   Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366
[8]   Blood vessel formation: What is its molecular basis? [J].
Folkman, J ;
DAmore, PA .
CELL, 1996, 87 (07) :1153-1155
[9]   Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells [J].
Gerber, HP ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :13313-13316
[10]   New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J].
Holash, J ;
Wiegand, SJ ;
Yancopoulos, GD .
ONCOGENE, 1999, 18 (38) :5356-5362